Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Filings indexed 916 across all filing types
Latest filing 2015-01-05 Declaration of Voting R…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document header explicitly states "Voting Rights Announcements" and references German securities law (§ 26 Abs. 1 WpHG, § 25a Abs. 1 WpHG). The content details changes in voting rights percentages (crossing thresholds of 10%) held by Société Générale S.A. in STADA Arzneimittel AG. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or, in this context, mandatory notifications regarding significant changes in share ownership/voting power.
2015-01-05 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly references Article 26a of the WpHG (German Securities Trading Act). It states the total number of voting rights as of December 30, 2014. This content directly relates to the official announcement of voting rights or changes therein, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA). Although it is not the final result of a vote, it is a mandatory regulatory disclosure concerning the total voting power, which is a core component of DVA filings.
2014-12-30 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states in the header and content that it is a "Voting Rights Announcement" (Veröffentlichung nach § 26 Absatz 1 WpHG). This type of filing reports changes in significant share ownership thresholds, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although the header mentions "Voting Rights Announcements," the content details the crossing of a threshold (10%) by Société Générale S.A., which is the core function of an MRQ filing under German regulations (WpHG).
2014-12-03 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of Voting Rights as of the end of November 2014 (60,606,940). This directly relates to the announcement of voting rights or capital structure changes related to shareholder votes. Reviewing the definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most specific fit, as it covers official results from shareholder votes or related announcements like total voting rights updates. Although it is a short announcement, it is the primary content, not an announcement *of* another report, making DVA more appropriate than RPA or RNS.
2014-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains a 'Notification of voting rights pursuant to Art. 25a, Sec. 1 WpHG'. It details a change in the voting rights proportion held by Société Générale S.A. in STADA Arzneimittel AG, specifically noting a 'Falling below threshold' event related to ownership percentages. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2014-11-18 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains a 'Notification of voting rights pursuant to Art. 25a, Sec. 1 WpHG'. It details the crossing of a voting rights threshold (10%) by a notifier (Société Générale S.A.) in the listed company (STADA Arzneimittel AG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Although it is a regulatory filing, DVA is the most specific category available.
2014-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.